Catalyst Wire Dossier Catalyst Wire Dossier

AUR112

· Aurigene Discovery Technologies Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AUR112, covering 2026-01-13 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating Safety Pharmacokinetics and Pharmacodynamics of AUR112 in Patients With Relapsed Advanced Lymphoma [Phase 1]

See pricing